Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …
News
pills

The future of generic drugs and strategies for commercial success

February 17, 2017 Medical Communications generics

GBI Research examines whether the US continue to dominate the global generic drug market.
News

Zydus Cadila scores twin FDA approvals

February 17, 2017 Medical Communications, Sales and Marketing FDA, Zydus Cadila

Indian pharmaceutical firm Zydus Cadila has announced that the US Food and Drug Administration (FDA) has given the go-ahead for …
News
astrazeneca_logo_building

AstraZeneca’s drug scores positive results against chemo in breast cancer

February 17, 2017 Medical Communications, Research and Development AstraZeneca

AstraZeneca announced that its drug, Lynpara (olaparib), had positive results for a recent Phase 3 trial when tested against standard …
News
takeda_tokyo_hq

Takeda and TiGenix announce successful trial of Crohn’s disease drug

February 17, 2017 Medical Communications, Sales and Marketing Takeda, TiGenix

Takeda and TiGenix announced Phase 3 results from a trial looking into the investigational compound Cx601, a treatment for refractory …
News
donald_trump_september_3_2015

What does Trump’s victory mean for the pharma, biotech and healthcare sectors?

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Trump

After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark …
Feature
down_arrow

Hepatitis C market set for slump as cure rates rise

February 14, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Gilead, hepatitis C

Objectively, it is the pharmaceutical industries intention to find cures for diseases and to aid patients to live a full …
News

Pfizer and Flynn: How are ‘excessive’ prices for generic drugs possible and should competition authorities do more about exploitative pricing?

February 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, Pfizer, flynn

As last year came to a close, the headlines were rocked by the news that pharma giant Pfizer had been …
Feature
erez_vigodman

Teva’s Vigodman becomes third CEO to leave in 5 years

February 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Teva has maintained its habit of changing CEOs rather frequently, as Erez Vigodman has left by “mutual agreement”. He becomes …
Appointment
thomas-cueni

Thomas Cueni named as new IFPMA Director General

February 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IFPMA

Thomas Cueni has become the new Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and will …
Appointment
intelligent_fingerprinting

Intelligent Fingerprinting secures £3 million funding for portable drug screening

February 10, 2017 Medical Communications, Research and Development Intelligent Fingerprinting, drug testing, nanotechnology

Intelligent Fingerprinting has received a funding boost to market its fingerprint-based drug screening system further. It is the world’s first …
News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

February 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

Two of our top five stories this month are about one company in particular – a company that’s having a …
News

Vital Signs: Partnerships between industry, providers and academia

February 10, 2017 Medical Communications Deloitte

Hanno Ronte, life sciences partner at Deloitte, writes upon the opportunities available when a collaborative environment between industry, providers and …
News
brexit

Brexit could delay key drugs to UK patients, ex-MHRA chairman claims

February 10, 2017 Medical Communications, Sales and Marketing Cancer, MHRA, brexit

Former UK regulator and ex-chairman of the Medicines and Healthcare products Regulatory Agency (MHRA) Sir Alasdair Breckenridge has warned that …
News
fda2outsideweb

FDA approves first treatment for Duchenne muscular dystrophy

February 10, 2017 Medical Communications, Sales and Marketing Duchenne Muscular Dystrophy, FDA, marathon, marathon pharmaceuticals

The FDA has announced that it has approved Emflaza (deflazacort), developed by Marathon Pharmaceuticals. The treatment will arrive on the …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026